Core Viewpoint - Yingkang Life (300143) emphasizes its commitment to monitoring advancements in cutting-edge technologies and public health needs, indicating a cautious approach to exploring new opportunities based on social value, technical feasibility, and business synergy [1] Group 1 - The company is attentive to the development of frontier technologies and public health demands [1] - Any expansion into new areas will undergo careful research and validation across multiple dimensions [1] - The company will fulfill its disclosure obligations in accordance with regulations if there are substantial developments in this field that meet disclosure standards [1]

Core Viewpoint - The company emphasizes the importance of accounts receivable management and has established strict internal measures to ensure effective collection and credit risk control [1] Group 1: Accounts Receivable Management - The company prioritizes customer repayment ability during the product sales process [1] - An internal policy for accounts receivable management has been implemented to enhance collection efforts and manage credit risk dynamically [1] Group 2: Research and Development - The company focuses on technological innovation as a core driver for development, continuously iterating on its operating systems, cloud computing, and information security product lines [1] - In the first half of 2025, the company's R&D investment reached 44.293 million, representing a year-on-year increase of 12.81% due to increased employee compensation and stock incentive plans [1]